<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20220729</date><key>pmc.key</key><document><id>9322618</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.3390/tropicalmed7070116</infon><infon key="article-id_pmc">9322618</infon><infon key="article-id_pmid">35878128</infon><infon key="article-id_publisher-id">tropicalmed-07-00116</infon><infon key="elocation-id">116</infon><infon key="issue">7</infon><infon key="kwd">excess mortality pneumonia excess mortality COVID-19 Thailand</infon><infon key="license">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).</infon><infon key="name_0">surname:Wilasang;given-names:Chaiwat</infon><infon key="name_1">surname:Modchang;given-names:Charin</infon><infon key="name_2">surname:Lincharoen;given-names:Thanchanok</infon><infon key="name_3">surname:Chadsuthi;given-names:Sudarat</infon><infon key="name_4">surname:Adegnika;given-names:Ayola Akim</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">7</infon><infon key="year">2022</infon><offset>0</offset><text>Estimation of Excess All-Cause Mortality Due to COVID-19 in Thailand</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>69</offset><text>Thailand has experienced the most prominent COVID-19 outbreak in 2021, resulting in a new record for COVID-19 cases and deaths. To assess the influence of the COVID-19 outbreak on mortality, we estimated excess all-cause and pneumonia mortality in Thailand during the COVID-19 outbreak from April to October 2021. We used mortality from the previous 5 years to estimate the baseline number of deaths using generalized linear mixed models. The models were adjusted for seasonality and demographics. We found that, during the outbreak in 2021, there was a significant rise in excess fatalities, especially in the older age groups. The estimated cumulative excess death was 14.3% (95% CI: 8.6–18.8%) higher than the baseline. The results also showed that the excess deaths in males were higher than in females by approximately 26.3%. The excess deaths directly caused by the COVID-19 infections accounted for approximately 75.0% of the all-cause excess deaths. Furthermore, excess pneumonia deaths were also found to be 26.2% (95% CI: 4.8–46.0%) above baseline.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1132</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1148</offset><text>In late December 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, China. The disease then spread swiftly across the globe in early 2020. Thailand was the first country to report a COVID-19-infected person outside of mainland China and has recently experienced the most prominent COVID-19 outbreak in 2021. To mitigate the disease transmission, the Thai government implemented social distancing and stringent lockdown measures throughout the country and imposed international travel restrictions and nighttime curfews. Even though the interventions have proven to be effective in slowing down the spread of the disease, during the peak of the epidemic wave, hospitals in Thailand were running out of beds to accommodate COVID-19 patients and patients of other diseases. Although the Thai government set up the field hospitals for treating COVID-19 patients, the disease’s toll on mortality was still high. According to a report by the Department of Disease Control, Ministry of Public Health, Thailand, there have been 19,111 officially reported COVID-19 deaths as of 31 October 2021. This number of deaths reflects the significant impact of the COVID-19 outbreaks on mortality in Thailand.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2441</offset><text>To assess the impact of the outbreak on mortality, the approach for estimating excess mortality was utilized to quantify the increased deaths compared with the expected mortality. Excess mortality estimation has previously been used to investigate the effects of pollution, climate change, and epidemics (e.g., influenza, chikungunya, and HIV). Moreover, previous studies have also applied this approach to COVID-19, focusing on estimating the mortality burden of the COVID-19 outbreak using statistical models. In general, statistical models usually incorporate risk factors related to death (e.g., sex, age group, time, seasonality, and demographic change) as indicator functions for excess mortality estimation. For instance, Aburto et al. estimated the number of age- and sex-specific excess deaths adjusted for seasonality using generalized additive models (GAMs).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3311</offset><text>Estimating age- and sex-specific mortality is an essential consideration in COVID-19-related death. Age-specific mortality may vary by age due to a wide variety of factors. Most fatalities from COVID-19 have been reported to be relatively high in older age groups. Recent studies revealed that the proportion of elderly deaths has dramatically increased in many countries. Thus, disregarding the age structure of the population may result in inaccurate estimates of excess mortality. Sex-specific mortality is also important in estimating excess mortality. Different patterns of COVID-19 mortality have been observed among males and females in many countries. Therefore, tracking age- and sex-specific deaths is an important component of health surveillance.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4070</offset><text>In this study, we aimed to estimate excess mortality in Thailand from April to October 2021 to assess the impact of the COVID-19 outbreaks on mortality. We estimated the baseline number of deaths in a typical year (2015–2019) without COVID-19 using a generalized linear mixed model (GLMM). Our model incorporated several factors such as sex, age group, time, seasonality, and demographics. We then estimated the all-cause mortality from April to October 2021 compared to baseline.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>4553</offset><text>2. Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4578</offset><text>2.1. Estimating the Excess Mortality</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4615</offset><text>In order to estimate the excess mortality, we started our analysis by investigating the distribution of the observed sex-specific death counts from 2015 to 2019. We then used mortality data from January 2015 to December 2019 to estimate the baseline mortality in the absence of COVID-19. The mortality data were fitted by generalized linear mixed models (GLMMs) with a negative binomial link function. The models included linear mortality trends by gender, age, and seasonality. The structure of the models was as follows:       where  is the expected number of deaths at month ,  and  represent the gender and age group at month ,  and  are indicator variables (1: yes; 0: no), and  indicates the month starting from January 2015 to December 2019. Furthermore, the featuring trigonometric terms represent the seasonal effect, and all the terms fully interact with gender and age group.  indicates the month of the year. This model also captures a yearly trend of changing population structure. The monthly average population by age group and gender at month  () was used as an offset in the modeling. Here,  is a random effect in the model. The baseline was then created by averaging the death counts observed in each month starting from January 2015 to December 2019. We also compared our model with other GLMMs. We investigated how adjustments for seasonality might affect the baseline estimation. We constructed four models with two patterns of seasonality, including a full year period and a half-year period of seasonality(for full details, see the Supplementary Materials).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6196</offset><text>We then projected the baseline mortality forward until October 2021. The excess mortality in each month was defined as the number of reported deaths minus the baseline prediction. We subsequently summed the excess mortality estimates across all months, starting from April 2021 to October 2021, yielding the cumulative estimate of the excess mortality in Thailand.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6561</offset><text>All the analyses were implemented in R statistical software version 3.6.3. To calculate the 95% predictive intervals (PIs), we sampled death counts from a negative binomial distribution, following an approach developed by Aburto et al..</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6798</offset><text>2.2. Data</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6808</offset><text>We collected the monthly all-cause mortality data in Thailand from the Official Statistics Registration Systems in the human mortality database. The database compiles mortality statistics from Thailand’s Bureau of Registration Administration. The information was presented in the form of tables with age and gender categories. The mortality data from 2015 to 2019 were utilized to estimate the baseline mortality in the absence of COVID-19 in 2020–2021. Furthermore, data on traffic accident-related deaths were acquired from the Road Accidents Data Center for Road Safety Culture of Thailand (Thai RSC). The accident mortality data were also stratified by age group and gender. The number of people dying from traffic accidents was categorized into six age groups (0–14, 15–18, 19–24, 25–34, 35–60, and over 60 years of age).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7649</offset><text>The numbers of daily COVID-19 cases and deaths in Thailand were retrieved from the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Daily COVID-19 mortality data were summarized into monthly data for consistency with the monthly all-cause mortality. According to the COVID-19 mortality data, the number of confirmed deaths started to increase rapidly in early April 2021 (see Supplementary Figure S1). We, therefore, focused our attention on estimating the excess deaths from April to October 2021, a period in which the cumulative number of COVID-19 deaths exceeded 100.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8251</offset><text>The monthly pneumonia mortality data were obtained from the Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. The data were country-level without age and sex stratification, as that information was not available. We used the pneumonia mortality data from 2015 to 2019 to estimate the pneumonia baseline mortality in the absence of COVID-19 in 2020–2021.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8649</offset><text>We also obtained yearly population estimates from the Population Pyramids of the World from 2015 to 2021. The single-year population counts were aggregated to match the gender and age group of the mortality data. We employed the standard interpolation approach to estimate the monthly population by gender and age group. The monthly population counts were used as an offset in the modeling strategy to calculate the baseline mortality in Thailand.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>9097</offset><text>3. Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9108</offset><text>Thailand has been plagued by competition between Alpha and Delta variants since April 2021, resulting in Thailand’s most ever severe epidemic wave. The number of COVID-19 deaths has increased across the country (Figure S1). Until August 2021, daily deaths reached their peak with an average of 235 deaths per day. Following that, the death toll continued to decrease, with an average of 99 deaths per day in October. During April to late August, there were more than 10,000 officially COVID-19 confirmed deaths in Thailand.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9634</offset><text>This study estimated excess mortality in Thailand during the COVID-19 outbreak using GLMM. To do so, we first evaluated the ability of different models to retrospectively explain the mortality data from 2015 to 2019. The baseline mortality estimated using different models described in Section 2 is shown in Supplementary Figures S2–S9. A comparison of the models showed that GLMMs with a full year of seasonality were more consistent with the data. We found that the GLMM with age- and sex-specific effects for special months (i.e., the first and last months of a year) yielded the best result based on the Akaike information criterion (AIC) (Supplementary Table S1). The observed number of deaths is indicated by the points, and the expected number of deaths is illustrated by the solid line along with its 95% CI. Overall, the trends of monthly deaths generated from the model agree with the reported data. We also predicted the baseline mortality in 2020–2021 on the basis of the 2015–2019 mortality data. We found that the predicted baseline in 2020–2021 during the COVID-19 outbreak was higher than the reported mortality data in the younger age group (0–14) of men, whereas the predicted baseline in other age groups agreed with the mortality data.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>10900</offset><text>3.1. All-Cause Mortality during 2015–2021 in Thailand</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10956</offset><text>All-cause deaths by age group and sex from 2015 to 2021 in Thailand are illustrated in Figure 1 and Figure 2. To compare all-cause mortality trends in each age group, the number of reported total all-cause deaths was divided by the population in each age group. We observed some annual seasonal patterns of all-cause deaths, with higher death rates in the first and last months of a year for both men and women. The changes in mortality rate that occurred during the COVID-19 outbreak varied by age group. Death rates in younger people tended to be higher among younger age groups (0–14) in 2016, in which the highest accident fatality rate was also highest in this period. In 2021, the mortality rate continually declined in the younger age group (0–24) for both men and women. However, in age groups older than 25 years, the mortality was characteristic, in which an unusual mortality peak was observed. The mortality rate rapidly increased from June to August, with the mortality rate among men being higher than women. In the age group 36–60, the mortality rate was approximately twofold higher among men than women, and 1.5-fold higher in the age group over 60 years of age.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>12142</offset><text>3.2. Cumulative Excess Mortality</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12175</offset><text>The estimated cumulative excess deaths from April to October 2021 for men and women are shown in Figure 3. The expected number of all-cause excess deaths up to 31 October 2021 was 25,486 (95% CI: 13,913–36,862). We found that the cumulative death counts had risen by 14.3% (95% CI: 8.6–18.8%) above the baseline. The results showed that male excess deaths accounted for 55.8% (14,223) of total excess deaths, while female excess deaths accounted for 44.2% (11,263). These excess deaths included deaths caused by COVID-19 and other causes. Up to 31 October 2021, there were 19,111 officially reported COVID-19 deaths. After classifying the deaths caused by COVID-19, we found that the deaths attributed to COVID-19 accounted for 75.0% of the excess deaths throughout the study period, with the remaining 25.0% (6375) being indirectly attributed to COVID-19.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13036</offset><text>According to the time series of all-cause excess deaths, the number of excess deaths began to rise above the baseline in July 2021 (Figure 3), which was the first month that the daily number of COVID-19 deaths exceeded a hundred. For both men and women, excess deaths were obviously observed in age groups older than 25 years, whereas excess in age groups 15–18 and 19–24 were below the baseline with −18.1% and −12.0%, respectively (Figure 4). For children aged 0–14, the excess deaths decreased −19.6% compared with the expected level. The increases in mortality were observed in people aged 25–34 and 35–60 years, with 5.9% and 8.4% more deaths than expected. Among the six age groups, the oldest age groups (&gt;60 years of age) were most affected by the COVID-19 outbreak. People in the age group of more than 60 years were exposed to death at an 11.6% higher level than baseline, with men and women having a roughly similar trend. Furthermore, life expectancy by sex was also estimated using the life table (Supplementary Figure S10). We found that both male and female life expectancy at birth decreased in the year 2021. Female life expectancy at birth decreased from 78.3 to 76.1 years compared to the previous year. Similarly, male life expectancy at birth decreased from 71.6 years to 71.2 years in the same period.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>14376</offset><text>3.3. Correlation of Excess Deaths and COVID-19</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14423</offset><text>Our study demonstrated that the excess mortality across the country increased as a consequence of the COVID-19 epidemic. The results revealed that the excess deaths substantially increased over the course of the outbreak (Figure 5). Our model predicted that the excess mortality counts began to rise after the outbreak in April 2021. The disease spread to many provinces, with a maximum of 23,021 newly confirmed cases per day on 13 August 2021. We found that the trend of all-cause excess mortality agreed with the COVID-19 confirmed cases observed by the surveillance system. Quantitatively, the Pearson correlation coefficient between the cumulative cases and cumulative excess deaths was found to be 0.9912 (95% CI: 0.9392–0.9987). This correlation suggests that the COVID-19 outbreaks had an impact on excess mortality.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>15250</offset><text>3.4. Pneumonia Excess Mortality</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15282</offset><text>In this study, we also estimated the pneumonia excess mortality during the COVID-19 outbreak (for full details, see the Supplementary Materials). We found that the trend of pneumonia deaths continually decreased from 2015 to 2020 (Supplementary Figure S11). However, we observed unexpected pneumonia deaths in May 2021. Using the GLMMs, we estimated pneumonia excess deaths between April and October 2021. The pneumonia excess deaths are illustrated in Figure 6. The results suggested that the number of pneumonia excess deaths exceeded the baseline by 26.2% (95% CI: 4.8–46.0%) as of 31 October 2021. The cumulative pneumonia excess deaths were found to be 34 (95% CI: 6–58). Furthermore, the results showed that pneumonia excess deaths began to rise rapidly in April 2021, the same time period that COVID-19 began to spread in Thailand, and decreased slowly afterward.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>16157</offset><text>4. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16171</offset><text>In this study, we investigated the impact of COVID-19 outbreaks on excess mortality in Thailand. We estimated all-cause excess mortality in 2021 on the basis of historical mortality data from 2015 to 2019. We then analyzed the age- and sex-specific mortality during 2020–2021.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16450</offset><text>Using our best model, we estimated the excess mortality in Thailand from April to October 2021. Our results highlighted that the mortality burden was increased during this period, which would be a major challenge to the healthcare system. However, Thailand implemented social distancing and stringent lockdown measures, which comprised a national lockdown, border closure, restricting travel, and imposing nighttime curfews. The rapid rise in the number of confirmed cases resulted in the subsequent surge in the number of deaths. Our analysis suggested that death counts directly caused by the COVID-19 infection accounted for approximately 75.0% of the excess deaths. The remaining excess deaths might have been indirectly caused by COVID-19. People, who are ill with other diseases, may struggle to find treatment due to the impact of disruptions to the healthcare system during the COVID-19 outbreak. There have been reports of inadequate intensive care unit (ICU) beds and ventilators in Thailand. A shortage of ICU resources may lead to an increased risk of death for critically ill patients. Some hospitals also lacked blood supplies due to a dramatic decrease in blood donations, resulting in blood shortages throughout the country.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17691</offset><text>Our analysis shows that the excess mortality drastically increased with increasing age, which is broadly consistent with the estimates in other studies. The excess mortality was observed mostly in the age group above 60 years of age, accounting for 78.4% of the total excess mortality. These demographic characteristics of mortality agree with the risk of mortality due to the COVID-19 outbreak. Furthermore, recent clinical studies found that COVID-19 has a major impact on the elderly. Therefore, targeting primarily the elderly age group (via, e.g., vaccination) may reduce hospitalization and mortality rates.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18305</offset><text>In contrast, the COVID-19 outbreak seemed to have less of an impact on the younger age group (0–24 years). All-cause mortality in the younger age group may have decreased partly due to the reduction in traffic accident mortality. A recent study also pointed out that the reduction in deaths among the younger age groups may have been due to fewer car accidents and work-related accidents during the lockdown period. According to the WHO Global Status Report on Road Safety, Thailand ranked ninth in the world and first in Southeast Asia for road traffic deaths, with an estimated road traffic death rate of 33 deaths per 100,000 people in 2018. Moreover, traffic accidents were the third leading cause of death in Thailand in 2020. However, the data in 2021 suggest that traffic accident fatalities decreased substantially during the course of the COVID-19 outbreak (Supplementary Figure S12). The mobility data reported by Apple also suggested that driving and walking mobility tended to decrease during this period. The number of deaths caused by traffic accidents decreased markedly in the male population (Supplementary Figure S13). Specifically, the average number of deaths caused by traffic accidents decreased approximately 20% compared to the previous year. Therefore, our findings might reflect reduced all-cause mortality in the younger age group of men, partly due to the reduction in traffic accident mortality as a result of lockdown measures.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19765</offset><text>Our results showed higher excess deaths in males than in females. Although the trend of sex-specific deaths in 2021 compared to the previous four years showed a similar trend for men and women, the magnitude of excess mortality was higher for men, specifically in three age groups (25–34, 35–60, and over 60 years of age). There was a noticeable sex difference in excess mortality in age groups older than 25 years. These demographics of excess mortality were also found in other countries such as England and Wales, Sweden, Italy, and Brazil. These studies revealed that the majority of excess deaths were attributable to COVID-19. Moreover, other studies have suggested that the risk of COVID-related death in males may be related to susceptibility to severe SARS-CoV-2 infections and male hormones. Therefore, gender could be a risk factor for COVID-related mortality.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20641</offset><text>The increase in all-cause mortality in Thailand was mainly affected by the COVID-19 outbreak. Furthermore, during the same COVID-19 outbreak period, Thailand experienced excess pneumonia mortality (Figure 6). Our results showed that pneumonia mortality increased from April to October 2021, corresponding to the period of the COVID-19 outbreak. In this study, we analyzed pneumonia mortality because pneumonia could be a complication of COVID-19 and has symptoms or signs similar to those of COVID-19. Moreover, among COVID-19 patients, pneumonia was the leading cause of death. According to the pneumonia mortality data, the trend of pneumonia deaths continually decreased from 2015 to 2020 (Supplementary Figure S11). However, the mortality rate caused by pneumonia increased unexpectedly during the COVID-19 outbreak in April 2021. Furthermore, while the prevalence of influenza during the COVID-19 outbreak in Thailand tended to decrease, pneumonia mortality still increased. It is possible that the increase in pneumonia deaths could be attributed to COVID-19 or misclassified deaths. If the increase in excess pneumonia deaths is a misclassification of COVID-19 deaths, this would indicate that the true number of COVID-19 deaths might have been underestimated. This is a possible explanation for the increase in pneumonia deaths during the COVID-19 outbreak in 2021. However, because there appears to be insufficient evidence and a lack of data during the study period, we were unable to quantify the death toll of misclassified COVID-19 deaths. Moreover, we used life expectancy at birth as an indicator of population health in Thailand during the COVID-19 outbreak. The average number of years a newborn is expected to live might reflect the impact on mortality due to the COVID-19 outbreak. According to WHO and the World Bank data, the life expectancy at birth of the Thai population in 2020 tended to increase over time for both men and women. However, our estimations show that life expectancy dropped, with a reduction of 0.4 and 2.2 years for men and women, respectively, compared to the previous year. The results illustrate that life expectancy losses might have been due to the abrupt increase in mortality in both men and women during the COVID-19 outbreak. Interestingly, although COVID-19 tended to impact higher mortality among males than females, it contributed to higher life-expectancy losses in females than in males. However, the estimation of life expectancy was a crude estimate due to the limitation of data. Future studies should deal with this issue, which will need to be investigated.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23260</offset><text>Our study, however, had some limitations. In this work, we did not consider other influential factors of death, such as influenza and respiratory syncytial virus infection, due to the lack of data. The empirical findings from Suntronwong et al. revealed that the advent of COVID-19 may have changed human behavior, such as wearing face masks and social distancing, resulting in a decreased transmission of influenza in Thailand. In addition, we did not consider other factors such as effects of heatwaves and ambient air pollution that may correlate with mortality due to the limitation of data. Future work may investigate these factors when the data become available.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>23930</offset><text>5. Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>23945</offset><text>In summary, our findings showed that the COVID-19 outbreak in Thailand had a huge impact on mortality. During the outbreak in 2021, there was a significant rise in excess fatalities, especially in the older age groups. The increase in mortality was found to be higher in men than in women. It is worth stressing that up-to-date and reliable mortality data are essential to assess the impact of the COVID-19 pandemic. Our modeling results could potentially provide insights into the COVID-19 outbreaks and provide a guide for outbreak control and intervention.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">footnote</infon><offset>24505</offset><text>Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>24631</offset><text>Supplementary Materials</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>24655</offset><text>The following supporting information can be downloaded at . Table S1: Model comparison; Figure S1: Daily confirmed COVID-19 deaths; Figure S2: Men baseline mortality from Model A; Figure S3: Women baseline mortality from Model A; Figure S4: Men baseline mortality from Model B; Figure S5: Women baseline mortality from Model B; Figure S6: Men baseline mortality from Model C; Figure S7: Women baseline mortality from Model C; Figure S8: Men baseline mortality from Model D; Figure S9: Women baseline mortality from Model D; Figure S10: Life expectancy at birth; Figure S11: Pneumonia baseline mortality; Figure S12: Traffic accident mortality data and mobility trends data; Figure S13: Traffic accident deaths by gender and age groups.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>25391</offset><text>Author Contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>25412</offset><text>C.W. participated in study design, performed the analysis, and wrote the first draft; T.L. participated in data extraction and interpretation; C.M. participated in study design, analyzed the results, and wrote the manuscript; S.C. conceptualized the study, participated in its design, analyzed the results, and wrote the manuscript. All authors have read and agreed to the published version of the manuscript.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>25822</offset><text>Institutional Review Board Statement</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>25859</offset><text>The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Naresuan University (protocol code P1-0003/2565 and 18 January 2022).</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>26051</offset><text>Informed Consent Statement</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>26078</offset><text>Not applicable.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>26094</offset><text>Data Availability Statement</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>26122</offset><text>The data supporting the findings can be found in the main paper.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>26187</offset><text>Conflicts of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>26209</offset><text>The authors declare no conflict of interest.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>26254</offset><text>References</text></passage><passage><infon key="fpage">727</infon><infon key="lpage">733</infon><infon key="name_0">surname:Zhu;given-names:N.</infon><infon key="name_1">surname:Zhang;given-names:D.</infon><infon key="name_2">surname:Wang;given-names:W.</infon><infon key="name_3">surname:Li;given-names:X.</infon><infon key="name_4">surname:Yang;given-names:B.</infon><infon key="name_5">surname:Song;given-names:J.</infon><infon key="name_6">surname:Zhao;given-names:X.</infon><infon key="name_7">surname:Huang;given-names:B.</infon><infon key="name_8">surname:Shi;given-names:W.</infon><infon key="name_9">surname:Lu;given-names:R.</infon><infon key="pub-id_doi">10.1056/NEJMoa2001017</infon><infon key="pub-id_pmid">31978945</infon><infon key="section_type">REF</infon><infon key="source">N. Engl. J. Med.</infon><infon key="type">ref</infon><infon key="volume">382</infon><infon key="year">2020</infon><offset>26265</offset><text>A Novel Coronavirus from Patients with Pneumonia in China, 2019</text></passage><passage><infon key="fpage">e1262</infon><infon key="name_0">surname:Tadj;given-names:A.</infon><infon key="name_1">surname:Lahbib;given-names:S.S.M.</infon><infon key="pub-id_doi">10.54034/mic.e1262</infon><infon key="section_type">REF</infon><infon key="source">Microbes Infect. Chemother.</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">2021</infon><offset>26329</offset><text>Our Overall Current Knowledge of COVID 19: An Overview</text></passage><passage><infon key="fpage">1495</infon><infon key="lpage">1496</infon><infon key="name_0">surname:Chookajorn;given-names:T.</infon><infon key="name_1">surname:Kochakarn;given-names:T.</infon><infon key="name_2">surname:Wilasang;given-names:C.</infon><infon key="name_3">surname:Kotanan;given-names:N.</infon><infon key="name_4">surname:Modchang;given-names:C.</infon><infon key="pub-id_doi">10.1038/s41591-021-01471-x</infon><infon key="pub-id_pmid">34400842</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>26384</offset><text>Southeast Asia is an emerging hotspot for COVID-19</text></passage><passage><infon key="comment">Available online: https://ourworldindata.org/coronavirus/country/thailand</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>26435</offset><text>Thailand: Coronavirus Pandemic Country Profile</text></passage><passage><infon key="fpage">2002</infon><infon key="name_0">surname:Wilasang;given-names:C.</infon><infon key="name_1">surname:Jitsuk;given-names:N.C.</infon><infon key="name_2">surname:Sararat;given-names:C.</infon><infon key="name_3">surname:Modchang;given-names:C.</infon><infon key="pub-id_doi">10.1038/s41598-022-06008-x</infon><infon key="pub-id_pmid">35132106</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2022</infon><offset>26482</offset><text>Reconstruction of the transmission dynamics of the first COVID-19 epidemic wave in Thailand</text></passage><passage><infon key="fpage">4816</infon><infon key="lpage">4822</infon><infon key="name_0">surname:Boon-Itt;given-names:S.</infon><infon key="name_1">surname:Rompho;given-names:N.</infon><infon key="name_2">surname:Jiarnkamolchurn;given-names:S.</infon><infon key="name_3">surname:Skunkan;given-names:Y.</infon><infon key="pub-id_doi">10.1080/21645515.2021.1979378</infon><infon key="section_type">REF</infon><infon key="source">Hum. Vaccines Immunother.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2021</infon><offset>26574</offset><text>Interaction between age and health conditions in the intention to be vaccinated against COVID-19 in Thailand</text></passage><passage><infon key="comment">Available online: https://www.bangkokpost.com/thailand/general/2136647/covid-beds-running-out</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>26683</offset><text>COVID Beds Running Out</text></passage><passage><infon key="comment">Available online: https://asia.nikkei.com/Spotlight/Coronavirus/Thailand-faces-hospital-bed-shortage-amid-3rd-COVID-wave</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>26706</offset><text>Thailand Faces Hospital Bed Shortage Amid 3rd COVID Wave</text></passage><passage><infon key="fpage">47</infon><infon key="name_0">surname:Marshall;given-names:A.I.</infon><infon key="name_1">surname:Archer;given-names:R.</infon><infon key="name_2">surname:Witthayapipopsakul;given-names:W.</infon><infon key="name_3">surname:Sirison;given-names:K.</infon><infon key="name_4">surname:Chotchoungchatchai;given-names:S.</infon><infon key="name_5">surname:Sriakkpokin;given-names:P.</infon><infon key="name_6">surname:Srisookwatana;given-names:O.</infon><infon key="name_7">surname:Teerawattananon;given-names:Y.</infon><infon key="name_8">surname:Tangcharoensathien;given-names:V.</infon><infon key="pub-id_doi">10.1186/s12961-021-00696-z</infon><infon key="pub-id_pmid">33789671</infon><infon key="section_type">REF</infon><infon key="source">Health Res. Policy Syst.</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2021</infon><offset>26763</offset><text>Developing a Thai national critical care allocation guideline during the COVID-19 pandemic: A rapid review and stakeholder consultation</text></passage><passage><infon key="fpage">1206</infon><infon key="lpage">1211</infon><infon key="name_0">surname:Aumpan;given-names:N.</infon><infon key="name_1">surname:Vilaichone;given-names:R.-k.</infon><infon key="name_2">surname:Ratana-Amornpin;given-names:S.</infon><infon key="name_3">surname:Teerakapibal;given-names:S.</infon><infon key="name_4">surname:Toochinda;given-names:P.</infon><infon key="name_5">surname:Witoonchart;given-names:G.</infon><infon key="name_6">surname:Nitikraipot;given-names:S.</infon><infon key="pub-id_doi">10.1016/j.jiph.2021.07.019</infon><infon key="pub-id_pmid">34419704</infon><infon key="section_type">REF</infon><infon key="source">J. Infect. Public Health</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2021</infon><offset>26899</offset><text>Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital</text></passage><passage><infon key="comment">Available online: https://ourworldindata.org/covid-deaths</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>27033</offset><text>Coronavirus (COVID-19) Deaths</text></passage><passage><infon key="elocation-id">1445</infon><infon key="name_0">surname:Murtas;given-names:R.</infon><infon key="name_1">surname:Russo;given-names:A.G.</infon><infon key="pub-id_doi">10.1186/s12889-019-7788-8</infon><infon key="pub-id_pmid">31684915</infon><infon key="section_type">REF</infon><infon key="source">BMC Public Health</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2019</infon><offset>27063</offset><text>Effects of pollution, low temperature and influenza syndrome on the excess mortality risk in winter 2016–2017</text></passage><passage><infon key="fpage">e360</infon><infon key="lpage">e367</infon><infon key="name_0">surname:Gasparrini;given-names:A.</infon><infon key="name_1">surname:Guo;given-names:Y.</infon><infon key="name_2">surname:Sera;given-names:F.</infon><infon key="name_3">surname:Vicedo-Cabrera;given-names:A.M.</infon><infon key="name_4">surname:Huber;given-names:V.</infon><infon key="name_5">surname:Tong;given-names:S.</infon><infon key="name_6">surname:Coelho;given-names:M.d.S.Z.S.</infon><infon key="name_7">surname:Saldiva;given-names:P.H.N.</infon><infon key="name_8">surname:Lavigne;given-names:E.</infon><infon key="name_9">surname:Correa;given-names:P.M.</infon><infon key="pub-id_doi">10.1016/S2542-5196(17)30156-0</infon><infon key="pub-id_pmid">29276803</infon><infon key="section_type">REF</infon><infon key="source">Lancet Planet. Health</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">2017</infon><offset>27175</offset><text>Projections of temperature-related excess mortality under climate change scenarios</text></passage><passage><infon key="fpage">898</infon><infon key="lpage">907</infon><infon key="name_0">surname:Cooper;given-names:B.S.</infon><infon key="name_1">surname:Kotirum;given-names:S.</infon><infon key="name_2">surname:Kulpeng;given-names:W.</infon><infon key="name_3">surname:Praditsitthikorn;given-names:N.</infon><infon key="name_4">surname:Chittaganpitch;given-names:M.</infon><infon key="name_5">surname:Limmathurotsakul;given-names:D.</infon><infon key="name_6">surname:Day;given-names:N.P.</infon><infon key="name_7">surname:Coker;given-names:R.</infon><infon key="name_8">surname:Teerawattananon;given-names:Y.</infon><infon key="name_9">surname:Meeyai;given-names:A.</infon><infon key="pub-id_doi">10.1093/aje/kwu360</infon><infon key="pub-id_pmid">25899091</infon><infon key="section_type">REF</infon><infon key="source">Am. J. Epidemiol.</infon><infon key="type">ref</infon><infon key="volume">181</infon><infon key="year">2015</infon><offset>27258</offset><text>Mortality attributable to seasonal influenza A and B infections in Thailand, 2005–2009: A longitudinal study</text></passage><passage><infon key="fpage">127</infon><infon key="lpage">134</infon><infon key="name_0">surname:Rosano;given-names:A.</infon><infon key="name_1">surname:Bella;given-names:A.</infon><infon key="name_2">surname:Gesualdo;given-names:F.</infon><infon key="name_3">surname:Acampora;given-names:A.</infon><infon key="name_4">surname:Pezzotti;given-names:P.</infon><infon key="name_5">surname:Marchetti;given-names:S.</infon><infon key="name_6">surname:Ricciardi;given-names:W.</infon><infon key="name_7">surname:Rizzo;given-names:C.</infon><infon key="pub-id_doi">10.1016/j.ijid.2019.08.003</infon><infon key="pub-id_pmid">31401203</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="year">2019</infon><offset>27369</offset><text>Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14–2016/17 seasons)</text></passage><passage><infon key="comment">Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731794/</infon><infon key="name_0">surname:Freitas;given-names:A.R.R.</infon><infon key="name_1">surname:Cavalcanti;given-names:L.</infon><infon key="name_2">surname:Von Zuben;given-names:A.P.</infon><infon key="name_3">surname:Donalisio;given-names:M.R.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>27498</offset><text>Excess Mortality Related to Chikungunya Epidemics in the Context of Co-Circulation of Other Arboviruses in Brazil</text></passage><passage><infon key="fpage">1064</infon><infon key="lpage">1068</infon><infon key="name_0">surname:Darby;given-names:S.</infon><infon key="name_1">surname:Rizza;given-names:C.</infon><infon key="name_2">surname:Doll;given-names:R.</infon><infon key="name_3">surname:Spooner;given-names:R.</infon><infon key="name_4">surname:Stratton;given-names:I.</infon><infon key="name_5">surname:Thakrar;given-names:B.</infon><infon key="pub-id_doi">10.1136/bmj.298.6680.1064</infon><infon key="pub-id_pmid">2497891</infon><infon key="section_type">REF</infon><infon key="source">Br. Med. J.</infon><infon key="type">ref</infon><infon key="volume">298</infon><infon key="year">1989</infon><offset>27612</offset><text>Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: Report on behalf of the directors of haemophilia centres in the United Kingdom</text></passage><passage><infon key="fpage">735</infon><infon key="lpage">740</infon><infon key="name_0">surname:Aburto;given-names:J.M.</infon><infon key="name_1">surname:Kashyap;given-names:R.</infon><infon key="name_2">surname:Schöley;given-names:J.</infon><infon key="name_3">surname:Angus;given-names:C.</infon><infon key="name_4">surname:Ermisch;given-names:J.</infon><infon key="name_5">surname:Mills;given-names:M.C.</infon><infon key="name_6">surname:Dowd;given-names:J.B.</infon><infon key="pub-id_doi">10.1136/jech-2020-215505</infon><infon key="pub-id_pmid">33468602</infon><infon key="section_type">REF</infon><infon key="source">J. Epidemiol. Community Health</infon><infon key="type">ref</infon><infon key="volume">75</infon><infon key="year">2021</infon><offset>27793</offset><text>Estimating the burden of the COVID-19 pandemic on mortality, life expectancy and lifespan inequality in England and Wales: A population-level analysis</text></passage><passage><infon key="fpage">797</infon><infon key="lpage">801</infon><infon key="name_0">surname:Stang;given-names:A.</infon><infon key="name_1">surname:Standl;given-names:F.</infon><infon key="name_2">surname:Kowall;given-names:B.</infon><infon key="name_3">surname:Brune;given-names:B.</infon><infon key="name_4">surname:Böttcher;given-names:J.</infon><infon key="name_5">surname:Brinkmann;given-names:M.</infon><infon key="name_6">surname:Dittmer;given-names:U.</infon><infon key="name_7">surname:Jöckel;given-names:K.-H.</infon><infon key="pub-id_doi">10.1016/j.jinf.2020.09.012</infon><infon key="pub-id_pmid">32956730</infon><infon key="section_type">REF</infon><infon key="source">J. Infect.</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="year">2020</infon><offset>27944</offset><text>Excess mortality due to COVID-19 in Germany</text></passage><passage><infon key="fpage">17</infon><infon key="lpage">22</infon><infon key="name_0">surname:Modig;given-names:K.</infon><infon key="name_1">surname:Ahlbom;given-names:A.</infon><infon key="name_2">surname:Ebeling;given-names:M.</infon><infon key="pub-id_doi">10.1093/eurpub/ckaa218</infon><infon key="pub-id_pmid">33169145</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Public Health</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2021</infon><offset>27988</offset><text>Excess mortality from COVID-19: Weekly excess death rates by age and sex for Sweden and its most affected region</text></passage><passage><infon key="fpage">213</infon><infon key="lpage">218</infon><infon key="name_0">surname:Gianicolo;given-names:E.A.L.</infon><infon key="name_1">surname:Russo;given-names:A.</infon><infon key="name_2">surname:Büchler;given-names:B.</infon><infon key="name_3">surname:Taylor;given-names:K.</infon><infon key="name_4">surname:Stang;given-names:A.</infon><infon key="name_5">surname:Blettner;given-names:M.</infon><infon key="pub-id_doi">10.1007/s10654-021-00717-9</infon><infon key="pub-id_pmid">33495860</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Epidemiol.</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2021</infon><offset>28101</offset><text>Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age</text></passage><passage><infon key="fpage">00458</infon><infon key="name_0">surname:Conti;given-names:S.</infon><infon key="name_1">surname:Ferrara;given-names:P.</infon><infon key="name_2">surname:Mazzaglia;given-names:G.</infon><infon key="name_3">surname:D’Orso;given-names:M.I.</infon><infon key="name_4">surname:Ciampichini;given-names:R.</infon><infon key="name_5">surname:Fornari;given-names:C.</infon><infon key="name_6">surname:Madotto;given-names:F.</infon><infon key="name_7">surname:Magoni;given-names:M.</infon><infon key="name_8">surname:Sampietro;given-names:G.</infon><infon key="name_9">surname:Silenzi;given-names:A.</infon><infon key="pub-id_doi">10.1183/23120541.00458-2020</infon><infon key="pub-id_pmid">33015145</infon><infon key="section_type">REF</infon><infon key="source">ERJ Open Res.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2020</infon><offset>28191</offset><text>Magnitude and time-course of excess mortality during COVID-19 outbreak: Population-based empirical evidence from highly impacted provinces in northern Italy</text></passage><passage><infon key="comment">Available online: https://stat.bora.dopa.go.th/stat/statnew/statMenu/newStat/home.php</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28348</offset><text>Official Statistics Registration Systems</text></passage><passage><infon key="comment">Available online: https://www.thairsc.com/</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28389</offset><text>Traffic Accident-Related Mortality Data</text></passage><passage><infon key="section_type">REF</infon><infon key="source">Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>28429</offset></passage><passage><infon key="comment">Available online: http://doe.moph.go.th/surdata/disease.php?dcontent=old&amp;ds=31</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28430</offset><text>Pneumonia</text></passage><passage><infon key="comment">Available online: https://www.populationpyramid.net/</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28440</offset><text>Population Pyramids of the World from 1950 to 2100</text></passage><passage><infon key="comment">Available online: https://reliefweb.int/report/thailand/coronavirus-disease-2019-covid-19-who-thailand-situation-report-197-19-august-2021</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28491</offset><text>Coronavirus Disease 2019 (COVID-19) WHO Thailand Situation Report 197—19 August 2021</text></passage><passage><infon key="comment">Available online: https://reliefweb.int/report/thailand/coronavirus-disease-2019-covid-19-who-thailand-situation-report-205-14-october-2021</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28578</offset><text>Coronavirus Disease 2019 (COVID-19) WHO Thailand Situation Report 205—14 October 2021</text></passage><passage><infon key="comment">Available online: https://dip.ddc.moph.go.th/new/%E0%B8%9A%E0%B8%A3%E0%B8%B4%E0%B8%81%E0%B8%B2%E0%B8%A3/3base_status_new</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28666</offset><text>Situation of Death from Traffic Accidents in Thailand</text></passage><passage><infon key="fpage">268</infon><infon key="lpage">270</infon><infon key="name_0">surname:Hanna;given-names:T.P.</infon><infon key="name_1">surname:Evans;given-names:G.A.</infon><infon key="name_2">surname:Booth;given-names:C.M.</infon><infon key="pub-id_doi">10.1038/s41571-020-0362-6</infon><infon key="pub-id_pmid">32242095</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Clin. Oncol.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2020</infon><offset>28720</offset><text>Cancer, COVID-19 and the precautionary principle: Prioritizing treatment during a global pandemic</text></passage><passage><infon key="fpage">2368</infon><infon key="lpage">2371</infon><infon key="name_0">surname:Rosenbaum;given-names:L.</infon><infon key="pub-id_doi">10.1056/NEJMms2009984</infon><infon key="pub-id_pmid">32302076</infon><infon key="section_type">REF</infon><infon key="source">N. Engl. J. Med.</infon><infon key="type">ref</infon><infon key="volume">382</infon><infon key="year">2020</infon><offset>28818</offset><text>The untold toll—The pandemic’s effects on patients without COVID-19</text></passage><passage><infon key="comment">Available online: https://english.redcross.or.th/news/blood-transfusion-services/5543/</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28890</offset><text>Impact of COVID-19 Pandemic on Blood Donation</text></passage><passage><infon key="comment">Available online: https://www.bangkokpost.com/thailand/general/2103991/red-cross-in-urgent-need-of-blood</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>28936</offset><text>Red Cross in Urgent Need of Blood</text></passage><passage><infon key="elocation-id">855</infon><infon key="name_0">surname:Dessie;given-names:Z.G.</infon><infon key="name_1">surname:Zewotir;given-names:T.</infon><infon key="pub-id_doi">10.1186/s12879-021-06536-3</infon><infon key="pub-id_pmid">34418980</infon><infon key="section_type">REF</infon><infon key="source">BMC Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2021</infon><offset>28970</offset><text>Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients</text></passage><passage><infon key="fpage">12530</infon><infon key="name_0">surname:Amore;given-names:S.</infon><infon key="name_1">surname:Puppo;given-names:E.</infon><infon key="name_2">surname:Melara;given-names:J.</infon><infon key="name_3">surname:Terracciano;given-names:E.</infon><infon key="name_4">surname:Gentili;given-names:S.</infon><infon key="name_5">surname:Liotta;given-names:G.</infon><infon key="pub-id_doi">10.1038/s41598-021-91992-9</infon><infon key="pub-id_pmid">34131216</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>29087</offset><text>Impact of COVID-19 on older adults and role of long-term care facilities during early stages of epidemic in Italy</text></passage><passage><infon key="fpage">140</infon><infon key="lpage">145</infon><infon key="name_0">surname:O’Driscoll;given-names:M.</infon><infon key="name_1">surname:Dos Santos;given-names:G.R.</infon><infon key="name_2">surname:Wang;given-names:L.</infon><infon key="name_3">surname:Cummings;given-names:D.A.</infon><infon key="name_4">surname:Azman;given-names:A.S.</infon><infon key="name_5">surname:Paireau;given-names:J.</infon><infon key="name_6">surname:Fontanet;given-names:A.</infon><infon key="name_7">surname:Cauchemez;given-names:S.</infon><infon key="name_8">surname:Salje;given-names:H.</infon><infon key="pub-id_doi">10.1038/s41586-020-2918-0</infon><infon key="pub-id_pmid">33137809</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">590</infon><infon key="year">2021</infon><offset>29201</offset><text>Age-specific mortality and immunity patterns of SARS-CoV-2</text></passage><passage><infon key="fpage">154</infon><infon key="name_0">surname:Kang;given-names:S.-J.</infon><infon key="name_1">surname:Jung;given-names:S.I.</infon><infon key="pub-id_doi">10.3947/ic.2020.52.2.154</infon><infon key="pub-id_pmid">32537961</infon><infon key="section_type">REF</infon><infon key="source">Infect. Chemother.</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">2020</infon><offset>29260</offset><text>Age-related morbidity and mortality among patients with COVID-19</text></passage><passage><infon key="fpage">1555</infon><infon key="lpage">1559.e1552</infon><infon key="name_0">surname:Hägg;given-names:S.</infon><infon key="name_1">surname:Jylhävä;given-names:J.</infon><infon key="name_2">surname:Wang;given-names:Y.</infon><infon key="name_3">surname:Xu;given-names:H.</infon><infon key="name_4">surname:Metzner;given-names:C.</infon><infon key="name_5">surname:Annetorp;given-names:M.</infon><infon key="name_6">surname:Garcia-Ptacek;given-names:S.</infon><infon key="name_7">surname:Khedri;given-names:M.</infon><infon key="name_8">surname:Boström;given-names:A.-M.</infon><infon key="name_9">surname:Kadir;given-names:A.</infon><infon key="pub-id_doi">10.1016/j.jamda.2020.08.014</infon><infon key="pub-id_pmid">32978065</infon><infon key="section_type">REF</infon><infon key="source">J. Am. Med. Dir. Assoc.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2020</infon><offset>29325</offset><text>Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care</text></passage><passage><infon key="name_0">surname:World Health Organization;given-names:W.</infon><infon key="section_type">REF</infon><infon key="source">Global Status Report on Road Safety 2018: Summary</infon><infon key="type">ref</infon><infon key="year">2018</infon><offset>29461</offset></passage><passage><infon key="fpage">131</infon><infon key="lpage">136</infon><infon key="name_0">surname:Chantith;given-names:C.</infon><infon key="name_1">surname:Permpoonwiwat;given-names:C.K.</infon><infon key="name_2">surname:Hamaide;given-names:B.</infon><infon key="pub-id_doi">10.1016/j.iatssr.2020.07.001</infon><infon key="section_type">REF</infon><infon key="source">IATSS Res.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2021</infon><offset>29462</offset><text>Measure of productivity loss due to road traffic accidents in Thailand</text></passage><passage><infon key="fpage">88</infon><infon key="lpage">100</infon><infon key="name_0">surname:Tanaboriboon;given-names:Y.</infon><infon key="name_1">surname:Satiennam;given-names:T.</infon><infon key="pub-id_doi">10.1016/S0386-1112(14)60122-9</infon><infon key="section_type">REF</infon><infon key="source">IATSS Res.</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2005</infon><offset>29533</offset><text>Traffic accidents in Thailand</text></passage><passage><infon key="comment">Available online: https://covid19.apple.com/mobility</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>29563</offset><text>COVID-19—Mobility Trends Reports Apple</text></passage><passage><infon key="elocation-id">1238</infon><infon key="name_0">surname:Michelozzi;given-names:P.</infon><infon key="name_1">surname:de Donato;given-names:F.</infon><infon key="name_2">surname:Scortichini;given-names:M.</infon><infon key="name_3">surname:Pezzotti;given-names:P.</infon><infon key="name_4">surname:Stafoggia;given-names:M.</infon><infon key="name_5">surname:De Sario;given-names:M.</infon><infon key="name_6">surname:Costa;given-names:G.</infon><infon key="name_7">surname:Noccioli;given-names:F.</infon><infon key="name_8">surname:Riccardo;given-names:F.</infon><infon key="name_9">surname:Bella;given-names:A.</infon><infon key="pub-id_doi">10.1186/s12889-020-09335-8</infon><infon key="pub-id_pmid">32795276</infon><infon key="section_type">REF</infon><infon key="source">BMC Public Health</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>29604</offset><text>Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities</text></passage><passage><infon key="fpage">3345</infon><infon key="lpage">3354</infon><infon key="name_0">surname:Jardim;given-names:B.C.</infon><infon key="name_1">surname:Santos;given-names:C.V.B.d.</infon><infon key="section_type">REF</infon><infon key="source">Ciênc. Saúde Coletiva</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2020</infon><offset>29686</offset><text>Excess mortality in Brazil in times of COVID-19</text></passage><passage><infon key="fpage">918</infon><infon key="lpage">927</infon><infon key="name_0">surname:Brandi;given-names:M.L.</infon><infon key="name_1">surname:Giustina;given-names:A.</infon><infon key="pub-id_doi">10.1016/j.tem.2020.09.003</infon><infon key="pub-id_pmid">33082024</infon><infon key="section_type">REF</infon><infon key="source">Trends Endocrinol. Metab.</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2020</infon><offset>29734</offset><text>Sexual dimorphism of coronavirus 19 morbidity and lethality</text></passage><passage><infon key="fpage">174548</infon><infon key="name_0">surname:Aksoyalp;given-names:Z.Ş.</infon><infon key="name_1">surname:Nemutlu-Samur;given-names:D.</infon><infon key="pub-id_doi">10.1016/j.ejphar.2021.174548</infon><infon key="pub-id_pmid">34606834</infon><infon key="section_type">REF</infon><infon key="source">Eur. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="volume">912</infon><infon key="year">2021</infon><offset>29794</offset><text>Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms</text></passage><passage><infon key="fpage">385</infon><infon key="lpage">386</infon><infon key="name_0">surname:Spagnolo;given-names:P.A.</infon><infon key="name_1">surname:Manson;given-names:J.E.</infon><infon key="name_2">surname:Joffe;given-names:H.</infon><infon key="pub-id_doi">10.7326/M20-1941</infon><infon key="pub-id_pmid">32384135</infon><infon key="section_type">REF</infon><infon key="source">Ann. Intern. Med.</infon><infon key="type">ref</infon><infon key="volume">173</infon><infon key="year">2020</infon><offset>29881</offset><text>Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us</text></passage><passage><infon key="fpage">756</infon><infon key="lpage">761</infon><infon key="name_0">surname:Zhao;given-names:D.</infon><infon key="name_1">surname:Yao;given-names:F.</infon><infon key="name_2">surname:Wang;given-names:L.</infon><infon key="name_3">surname:Zheng;given-names:L.</infon><infon key="name_4">surname:Gao;given-names:Y.</infon><infon key="name_5">surname:Ye;given-names:J.</infon><infon key="name_6">surname:Guo;given-names:F.</infon><infon key="name_7">surname:Zhao;given-names:H.</infon><infon key="name_8">surname:Gao;given-names:R.</infon><infon key="pub-id_doi">10.1093/cid/ciaa247</infon><infon key="pub-id_pmid">32161968</infon><infon key="section_type">REF</infon><infon key="source">Clin. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="year">2020</infon><offset>29959</offset><text>A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias</text></passage><passage><infon key="fpage">405</infon><infon key="name_0">surname:Perrone;given-names:F.</infon><infon key="name_1">surname:Piccirillo;given-names:M.C.</infon><infon key="name_2">surname:Ascierto;given-names:P.A.</infon><infon key="name_3">surname:Salvarani;given-names:C.</infon><infon key="name_4">surname:Parrella;given-names:R.</infon><infon key="name_5">surname:Marata;given-names:A.M.</infon><infon key="name_6">surname:Popoli;given-names:P.</infon><infon key="name_7">surname:Ferraris;given-names:L.</infon><infon key="name_8">surname:Marrocco-Trischitta;given-names:M.M.</infon><infon key="name_9">surname:Ripamonti;given-names:D.</infon><infon key="pub-id_doi">10.1186/s12967-020-02573-9</infon><infon key="pub-id_pmid">33087150</infon><infon key="section_type">REF</infon><infon key="source">J. Transl. Med.</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2020</infon><offset>30067</offset><text>Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial</text></passage><passage><infon key="fpage">839</infon><infon key="lpage">842</infon><infon key="name_0">surname:Raghu;given-names:G.</infon><infon key="name_1">surname:Wilson;given-names:K.C.</infon><infon key="pub-id_doi">10.1016/S2213-2600(20)30349-0</infon><infon key="pub-id_pmid">32758440</infon><infon key="section_type">REF</infon><infon key="source">Lancet Respir. Med.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2020</infon><offset>30161</offset><text>COVID-19 interstitial pneumonia: Monitoring the clinical course in survivors</text></passage><passage><infon key="fpage">L863</infon><infon key="lpage">L866</infon><infon key="name_0">surname:Witzenrath;given-names:M.</infon><infon key="name_1">surname:Kuebler;given-names:W.M.</infon><infon key="pub-id_doi">10.1152/ajplung.00447.2020</infon><infon key="pub-id_pmid">32996786</infon><infon key="section_type">REF</infon><infon key="source">Am. J. Physiol.-Lung Cell. Mol. Physiol.</infon><infon key="type">ref</infon><infon key="volume">319</infon><infon key="year">2020</infon><offset>30238</offset><text>Pneumonia in the face of COVID-19</text></passage><passage><infon key="fpage">225</infon><infon key="lpage">227</infon><infon key="name_0">surname:Suntronwong;given-names:N.</infon><infon key="name_1">surname:Thongpan;given-names:I.</infon><infon key="name_2">surname:Chuchaona;given-names:W.</infon><infon key="name_3">surname:Budi Lestari;given-names:F.</infon><infon key="name_4">surname:Vichaiwattana;given-names:P.</infon><infon key="name_5">surname:Yorsaeng;given-names:R.</infon><infon key="name_6">surname:Pasittungkul;given-names:S.</infon><infon key="name_7">surname:Kitphati;given-names:R.</infon><infon key="name_8">surname:Vongpunsawad;given-names:S.</infon><infon key="name_9">surname:Poovorawan;given-names:Y.</infon><infon key="pub-id_doi">10.1080/20477724.2020.1777803</infon><infon key="pub-id_pmid">32521210</infon><infon key="section_type">REF</infon><infon key="source">Pathog. Glob. Health</infon><infon key="type">ref</infon><infon key="volume">114</infon><infon key="year">2020</infon><offset>30272</offset><text>Impact of COVID-19 public health interventions on influenza incidence in Thailand</text></passage><passage><infon key="comment">Available online: https://apps.who.int/gho/data/view.main.61640?lang=en</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>30354</offset><text>Global Health Observatory Data Repository</text></passage><passage><infon key="comment">Available online: https://data.worldbank.org/indicator/SP.DYN.LE00.MA.IN?locations=TH</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>30396</offset><text>Life Expectancy at Birth Thailand</text></passage><passage><infon key="fpage">41</infon><infon key="lpage">50</infon><infon key="name_0">surname:Huang;given-names:C.</infon><infon key="name_1">surname:Cheng;given-names:J.</infon><infon key="name_2">surname:Phung;given-names:D.</infon><infon key="name_3">surname:Tawatsupa;given-names:B.</infon><infon key="name_4">surname:Hu;given-names:W.</infon><infon key="name_5">surname:Xu;given-names:Z.</infon><infon key="pub-id_doi">10.1016/j.envint.2018.08.058</infon><infon key="pub-id_pmid">30172927</infon><infon key="section_type">REF</infon><infon key="source">Environ. Int.</infon><infon key="type">ref</infon><infon key="volume">121</infon><infon key="year">2018</infon><offset>30430</offset><text>Mortality burden attributable to heatwaves in Thailand: A systematic assessment incorporating evidence-based lag structure</text></passage><passage><infon key="elocation-id">e0189909</infon><infon key="name_0">surname:Pinichka;given-names:C.</infon><infon key="name_1">surname:Makka;given-names:N.</infon><infon key="name_2">surname:Sukkumnoed;given-names:D.</infon><infon key="name_3">surname:Chariyalertsak;given-names:S.</infon><infon key="name_4">surname:Inchai;given-names:P.</infon><infon key="name_5">surname:Bundhamcharoen;given-names:K.</infon><infon key="pub-id_doi">10.1371/journal.pone.0189909</infon><infon key="pub-id_pmid">29267319</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2017</infon><offset>30553</offset><text>Burden of disease attributed to ambient air pollution in Thailand: A GIS-based approach</text></passage><passage><infon key="file">tropicalmed-07-00116-g001.jpg</infon><infon key="id">tropicalmed-07-00116-f001</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>30641</offset><text>All-cause mortality in men. Lines illustrate the mortality by six age groups (0–14, 15–18, 19–24, 25–34, 35–60, and over 60 years of age) starting from January 2015 to October 2021.</text></passage><passage><infon key="file">tropicalmed-07-00116-g002.jpg</infon><infon key="id">tropicalmed-07-00116-f002</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>30833</offset><text>All-cause mortality in women. Lines illustrate the mortality by six age groups (0–14, 15–18, 19–24, 25–34, 35–60, and over 60 years of age) starting from January 2015 to October 2021.</text></passage><passage><infon key="file">tropicalmed-07-00116-g003.jpg</infon><infon key="id">tropicalmed-07-00116-f003</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>31027</offset><text>Cumulative excess deaths by gender starting from April to October 2021. Lines illustrate the cumulative excess deaths by gender. Shaded areas show 95% prediction intervals.</text></passage><passage><infon key="file">tropicalmed-07-00116-g004.jpg</infon><infon key="id">tropicalmed-07-00116-f004</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>31200</offset><text>Cumulative excess deaths by gender and age groups. Lines illustrate the cumulative excess deaths by gender and age groups. Blue and orange lines represent men and women, respectively. Shaded areas indicate the 95% prediction intervals.</text></passage><passage><infon key="file">tropicalmed-07-00116-g005.jpg</infon><infon key="id">tropicalmed-07-00116-f005</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>31436</offset><text>Excess deaths and confirmed COVID-19 cases. Bars show cumulative COVID-19 cases from April to October 2021. The red line indicates cumulative all-cause excess deaths.</text></passage><passage><infon key="file">tropicalmed-07-00116-g006.jpg</infon><infon key="id">tropicalmed-07-00116-f006</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>31603</offset><text>Cumulative pneumonia excess deaths. The line illustrates the cumulative pneumonia excess deaths starting from April to October 2021; the shaded area indicates the 95% CI.</text></passage></document></collection>
